RIA Advisory Group
ADMA icon

RIA Advisory Group’s ADMA Biologics ADMA Stock Holding History

RIA Advisory Group’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-11,332
Closed -$94.8K – 135
2026
Q2 		$94.8K Buy
11,332
+476
+4% +$4.34K 0.02% 153
2026
Q1 		$97.8K Buy
+10,856
New +$171K 0.02% 143

Other funds holding ADMA

Marathon Capital Management
Marathon Capital Management Hunt Valley, Maryland $488M AUM 28.5% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Inspire Investing
Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return
Yousif Capital Management
Yousif Capital Management Bloomfield Hills, Michigan $8.87B AUM 34.1% 1-Year Est. Return
Amalgamated Bank
Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
City Center Advisors LLC
City Center Advisors LLC Troy, Michigan $131M AUM 24.02% 1-Year Est. Return

RIA Advisory Group's ADMA Position: Q3 2026 in Review

RIA Advisory Group sold out of ADMA Biologics (ADMA) in Q3 2026, closing a stake of 11,332 shares — an estimated $94.8K sold.

RIA Advisory Group first reported a position in ADMA in Q1 2026 and held it in 2 quarters. The position peaked at $97.8K in Q1 2026. 58 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.

  • RIA Advisory Group reported no remaining ADMA Biologics position as of Q3 2026 after selling out during the quarter.
  • RIA Advisory Group sold 11,332 ADMA Biologics shares in Q3 2026, an estimated $94.8K.
  • RIA Advisory Group first reported a position in ADMA Biologics in Q1 2026 and held it in 2 quarters.
  • RIA Advisory Group's ADMA Biologics position peaked at $97.8K in Q1 2026.
  • 58 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.

Based on RIA Advisory Group's 13F filing for Q3 2026, filed 15 Oct 2026.